» Articles » PMID: 11784770

Alpha7 Nicotinic Acetylcholine Receptors on GABAergic Interneurons Evoke Dendritic and Somatic Inhibition of Hippocampal Neurons

Overview
Journal J Neurophysiol
Specialties Neurology
Physiology
Date 2002 Jan 11
PMID 11784770
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

GABAergic interneurons in the hippocampus express high levels of alpha7 nicotinic acetylcholine receptors, but because of the diverse roles played by hippocampal interneurons, the impact of activation of these receptors on hippocampal output neurons (i.e., CA1 pyramidal cells) is unclear. Activation of hippocampal interneurons could directly inhibit pyramidal neuron activity but could also produce inhibition of other GABAergic cells leading to disinhibition of pyramidal cells. To characterize the inhibitory circuits activated by these receptors, exogenous acetylcholine was applied directly to CA1 interneurons in hippocampal slices, and the resulting postsynaptic responses were recorded from pyramidal neurons or interneurons. Inhibitory currents mediated by GABA(A) receptors were observed in 27/131 interneuron/pyramidal cell pairs, but no instances of disinhibition of spontaneous inhibitory events or GABA(B) receptor-mediated responses were observed. Two populations of bicuculline-sensitive GABA(A) receptor-mediated currents could be distinguished based on their kinetics and amplitude. Anatomical reconstructions of the interneurons in a subset of connected pairs support the hypothesis that these two populations correspond to inhibitory synapses located either on the somata or dendrites of pyramidal cells. In 11 interneuron/interneuron cell pairs, one presynaptic neuron was observed that produced strong inhibitory currents in several nearby interneurons, suggesting that disinhibition of pyramidal neurons may also occur. All three types of inhibitory responses (somatic-pyramidal, dendritic-pyramidal, and interneuronal) were blocked by the alpha7 receptor-selective antagonist methyllycaconitine. These data suggest activation of these functionally distinct circuits by alpha7 receptors results in significant inhibition of both hippocampal pyramidal neurons as well as interneurons.

Citing Articles

Dose-dependent effects of GAT107, a novel allosteric agonist-positive allosteric modulator (ago-PAM) for the α7 nicotinic cholinergic receptor: a BOLD phMRI and connectivity study on awake rats.

Brems B, Sullivan E, Connolly J, Zhang J, Chang A, Ortiz R Front Neurosci. 2023; 17:1196786.

PMID: 37424993 PMC: 10326388. DOI: 10.3389/fnins.2023.1196786.


Activation of the p11/SMARCA3/Neurensin-2 pathway in parvalbumin interneurons mediates the response to chronic antidepressants.

Umschweif G, Medrihan L, McCabe K, Sagi Y, Greengard P Mol Psychiatry. 2021; 26(7):3350-3362.

PMID: 33723417 PMC: 8505248. DOI: 10.1038/s41380-021-01059-4.


Selective coactivation of α7- and α4β2-nicotinic acetylcholine receptors reverses beta-amyloid-induced synaptic dysfunction.

Roberts J, Stokoe S, Sathler M, Nichols R, Kim S J Biol Chem. 2021; 296:100402.

PMID: 33571523 PMC: 7961090. DOI: 10.1016/j.jbc.2021.100402.


Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia.

Koola M, Praharaj S, Pillai A Curr Behav Neurosci Rep. 2020; 6(2):37-50.

PMID: 32601581 PMC: 7323923. DOI: 10.1007/s40473-019-00174-5.


Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling.

Papke R, Lindstrom J Neuropharmacology. 2020; 168:108021.

PMID: 32146229 PMC: 7610230. DOI: 10.1016/j.neuropharm.2020.108021.